Winslow Evans & Crocker’s BioTelemetry, Inc. BEAT Stock Holding History

Winslow Evans & Crocker’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,030	Closed	-$66K	–	1410
2019 Q1	$66K	Sell	1,030 -3,396	-77%	-$233K	0.02%	448
2018 Q4	$266K	Hold	4,426	–	–	0.09%	223
2018 Q3	$286K	Buy	4,426 +4,226	+2,113%	+$236K	0.09%	226
2018 Q2	$10K	Buy	+200	New	+$7.97K	﹤0.01%	823
2017 Q4	–	Sell	-3,300	Closed	-$109K	–	1180
2017 Q3	$109K	Buy	+3,300	New	+$114K	0.04%	348

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Winslow Evans & Crocker's BEAT Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 1,030 shares — an estimated $66K sold.

Winslow Evans & Crocker first reported a position in BEAT in Q3 2017 and held it in 5 quarters. The position peaked at $286K in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Winslow Evans & Crocker reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Winslow Evans & Crocker sold 1,030 BioTelemetry, Inc. shares in Q2 2019, an estimated $66K.
Winslow Evans & Crocker first reported a position in BioTelemetry, Inc. in Q3 2017 and held it in 5 quarters.
Winslow Evans & Crocker's BioTelemetry, Inc. position peaked at $286K in Q3 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.